Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

Clinical trial NCT02579967 · RECRUITING

Trial details

NCT number: NCT02579967
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary T-cell Immunodeficiency Disorders Common Variable Immunodeficiency Immune System Diseases Autoimmune Lymphoproliferative Lymphoproliferative Disorders

Start date: 2015-11-19
Primary completion: 2031-12-31
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.